GlaxoSmithKline CEO reshuffles 40% of management team by Arlene Weintraub Tuesday, January 9, 2018 GlaxoSmithKline CEO Emma Walmsley has replaced 40% of the company’s top management as she aims to reposition the struggling pharma giant.
